Norah Lynn Henry

University Of Michigan At Ann Arbor

$2,564,193

Attributed

$2,564,193

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $445.1K · FY2009–25

$500K$375K$250K$125K$0

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$2,564,193 · 3

By mechanism

R01$1,449,016 · 1

K07$687,344 · 1

R21$427,833 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of Michigan At Ann Arbor

Same institution · by research overlap

Kevin Anthony Kerber$6,378,264
Mark A Supiano$3,404,723
Kellie M Breen$5,250,230
Carol M Foster$842,930
James Michael Rae$16,701,485

Others in their field

Top investigators on “Malignant Breast Neoplasm”

David Heimbrook · Leidos Biomedical Research, Inc.$347,312,063
Norman Wolmark · Nsabp Foundation, Inc.$122,067,540
Walter John Curran · Thomas Jefferson University$97,002,422
Monica M Bertagnolli · Strang Cancer Prevention Center$84,975,759
Joseph P. Costantino · University Of Pittsburgh At Pittsburgh$68,847,428
Jan C Buckner · Mayo Clinic Coll Of Medicine, Rochester$60,763,376

Research focus

Malignant Breast NeoplasmWomanToxic EffectUnited StatesHormone TherapyOvarianTamoxifenOvarian AblationProgramsHigh RiskAblationFundingMonitorSeriesPremenopauseCohortBaseLeadAromatase InhibitorsAdherenceCancer RecurrenceMortalityGenetic PolymorphismBreast Cancer Survivor